Video
18 Sep 2020
Skyepharma - "What do we mean by Fully Integrated CDMO ?"
Content provided by our supplier
SKYEPHARMA PRODUCTION S.A.S
-
FR -
2017On CPHI since
Other Content from SKYEPHARMA PRODUCTION S.A.S (15)
-
News Skyepharma selects Veratrak platform to ensure secure data storing and sharing
Using Veratrak's platform, the CDMO will have full oversight of data, including an audit trail of data and document processes -
Brochure Company brochure
Through 25 years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is a leader in the field of classic and complex oral solid dosage forms. -
Brochure Skyepharma booklet of services
We support our clients through the whole product value chain with expert teams involved at the very beginning of every project. - Pharmaceutical development services - Technology offer for complex oral solid forms - Analytical services - Manufacturing & packaging capabilities - Serialization & aggregation service ready -
Whitepaper Recent development in complex tablet formulation design
In this article, Mathieu Degomme, PharmD, Pharmaceutical Development Project Manager, and Aline Moulin, PhD, Pharmaceutical Development Director, both of Skyepharma, outline three case studies from recent early-stage development programmes to illustrate what kind of complex tablets can be developed to meet specific target dissolution profiles for versatile applications. -
Whitepaper CPHI 2018_Pharma Insight Briefings
Aline Moulin, Head of New Product Introduction Department (NPI), presented different case studies during the Pharma Insight Briefings 2018 (CPHI Worldiwide): "COMPACTION SIMULATION AS A POWERFUL QUALITY BY DESIGN (QbD) TOOL How Skyepharma can help you to shorten the time and reduce the cost of pharmaceutical development programmes" -
Whitepaper CPHI 2017_Pharma Insight Briefings
Lucile Kowalsky, Project Manager in the New Product Introduction (NPI) department presented a case study during the Pharma Insight Briefings (CPHI Worldwide 2017) : "Quality by Design and Expertise:Accelerating time to market of complex oral solid dosage Accelerating time to market." -
Whitepaper Analytical Development & Technico Regulatory Expertise
We are able to develop analytical methods in a limited time, from bibliography study, screening parameters and conditions to sample preparation and assessment of robustness. -
Video Skyepharma at CPHI Worldwide 2018
David Lescuyer, Executive Vice President and Frederic Checo, Pharmaceutical Development Leader, both from Skyepharma speaks with CPHI TV at CPHI Worldwide in Madrid, Spain -
Video Skyepharma - Packaging services 2020
- Bottle packaging - Blister packaging
- Stick-packs
- Serialization & aggregation services (Seavision systems) -
Video Skyepharma - "What do we mean by Agile CDMO ?"
For Skyepharma, to be agile qualifies our ability to mobilize experts and work together to solve complex efficiently and rapidly. Skyepharma, your AGILE CDMO partner for tailor-made solutions. -
Video Skyepharma - "What do we mean by Reliable CDMO ?"
For Skyepharma, being reliable means taht we are able to meet our customers' needs on time and to the expected level of quality. Skyepharma your reliable CDMO for faster time to market without compromising on product quality -
Video CPHI Worldwide 2019 | Interview with Skyepharma
.Skyepharma's interview shows the company's growth since last year. David Lescuyer, Florence Lemoult and Frédéric Checot are the interviewees
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance